Ritholtz Wealth Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $763K | Buy |
+6,076
| New | +$763K | 0.02% | 518 |
|
|
2023
Q1 | – | Sell |
-725
| Closed | -$201K | – | 645 |
|
|
2022
Q4 | $201K | Sell |
725
-1,158
| -61% | -$321K | 0.01% | 537 |
|
|
2022
Q3 | $503K | Buy |
1,883
+345
| +22% | +$92.2K | 0.03% | 397 |
|
|
2022
Q2 | $314K | Buy |
1,538
+466
| +43% | +$95.1K | 0.02% | 410 |
|
|
2022
Q1 | $226K | Sell |
1,072
-233
| -18% | -$49.1K | 0.02% | 480 |
|
|
2021
Q4 | $313K | Sell |
1,305
-936
| -42% | -$224K | 0.02% | 400 |
|
|
2021
Q3 | $634K | Buy |
2,241
+2
| +0.1% | +$566 | 0.04% | 218 |
|
|
2021
Q2 | $775K | Buy |
2,239
+702
| +46% | +$243K | 0.06% | 185 |
|
|
2021
Q1 | $430K | Buy |
1,537
+350
| +29% | +$97.9K | 0.04% | 233 |
|
|
2020
Q4 | $291K | Sell |
1,187
-105
| -8% | -$25.7K | 0.03% | 258 |
|
|
2020
Q3 | $367K | Buy |
1,292
+525
| +68% | +$149K | 0.04% | 176 |
|
|
2020
Q2 | $205K | Buy |
+767
| New | +$205K | 0.03% | 236 |
|